176 related articles for article (PubMed ID: 30445944)
1. A tight balance of Karyopherin β1 expression is required in cervical cancer cells.
Carden S; van der Watt P; Chi A; Ajayi-Smith A; Hadley K; Leaner VD
BMC Cancer; 2018 Nov; 18(1):1123. PubMed ID: 30445944
[TBL] [Abstract][Full Text] [Related]
2. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.
van der Watt PJ; Maske CP; Hendricks DT; Parker MI; Denny L; Govender D; Birrer MJ; Leaner VD
Int J Cancer; 2009 Apr; 124(8):1829-40. PubMed ID: 19117056
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
Chi RA; van der Watt P; Wei W; Birrer MJ; Leaner VD
BMC Cancer; 2021 Feb; 21(1):106. PubMed ID: 33530952
[TBL] [Abstract][Full Text] [Related]
4. Novel small molecule inhibitor of Kpnβ1 induces cell cycle arrest and apoptosis in cancer cells.
Ajayi-Smith A; van der Watt P; Mkwanazi N; Carden S; Trent JO; Leaner VD
Exp Cell Res; 2021 Jul; 404(2):112637. PubMed ID: 34019908
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cells.
Angus L; van der Watt PJ; Leaner VD
Carcinogenesis; 2014 May; 35(5):1121-31. PubMed ID: 24398670
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Kpnβ1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.
Sheng C; Qiu J; He Z; Wang H; Wang Q; Guo Z; Zhu L; Ni Q
Oncol Rep; 2018 Feb; 39(2):554-564. PubMed ID: 29251332
[TBL] [Abstract][Full Text] [Related]
7. KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.
Stelma T; Leaner VD
Oncotarget; 2017 May; 8(20):32833-32847. PubMed ID: 28427184
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic.
van der Watt PJ; Chi A; Stelma T; Stowell C; Strydom E; Carden S; Angus L; Hadley K; Lang D; Wei W; Birrer MJ; Trent JO; Leaner VD
Mol Cancer Ther; 2016 Apr; 15(4):560-73. PubMed ID: 26832790
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.
He S; Miao X; Wu Y; Zhu X; Miao X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Wang Y; Xu X
J Cancer Res Clin Oncol; 2016 Mar; 142(3):561-72. PubMed ID: 26498772
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Kpnβ1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activity.
van der Watt PJ; Ngarande E; Leaner VD
PLoS One; 2011; 6(11):e27723. PubMed ID: 22125623
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis.
Zhu J; Wang Y; Huang H; Yang Q; Cai J; Wang Q; Gu X; Xu P; Zhang S; Li M; Ding H; Yang L
Tumour Biol; 2016 Jan; 37(1):661-72. PubMed ID: 26242264
[TBL] [Abstract][Full Text] [Related]
12. High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway.
Wang H; Wang D; Li C; Zhang X; Zhou X; Huang J
Tissue Cell; 2018 Apr; 51():39-48. PubMed ID: 29622086
[TBL] [Abstract][Full Text] [Related]
13. The nuclear import receptor Kpnβ1 and its potential as an anticancer therapeutic target.
van der Watt PJ; Stowell CL; Leaner VD
Crit Rev Eukaryot Gene Expr; 2013; 23(1):1-10. PubMed ID: 23557333
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
Yang L; Hu B; Zhang Y; Qiang S; Cai J; Huang W; Gong C; Zhang T; Zhang S; Xu P; Wu X; Liu J
Med Oncol; 2015 Apr; 32(4):128. PubMed ID: 25794490
[TBL] [Abstract][Full Text] [Related]
15. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
16. Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin.
Hussain A; Sharma C; Khan S; Shah K; Haque S
Asian Pac J Cancer Prev; 2015; 16(7):2939-46. PubMed ID: 25854386
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
18. The Phytochemical Indicaxanthin Synergistically Enhances Cisplatin-Induced Apoptosis in HeLa Cells via Oxidative Stress-Dependent p53/p21
Allegra M; D'Anneo A; Frazzitta A; Restivo I; Livrea MA; Attanzio A; Tesoriere L
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630700
[TBL] [Abstract][Full Text] [Related]
19. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition.
Vidya Priyadarsini R; Senthil Murugan R; Maitreyi S; Ramalingam K; Karunagaran D; Nagini S
Eur J Pharmacol; 2010 Dec; 649(1-3):84-91. PubMed ID: 20858478
[TBL] [Abstract][Full Text] [Related]
20. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
